#7cbde1_Small_Sep-Oct 2024 DRA Journal Cover

The latest DRA Journal issue showcases Asia's dental innovation, featuring Thailand's pioneering stem cell research, advanced clinical techniques like 3D-printed dentures for senior patients and digital workflows for implant restorations, a review of top Asian dental startups, and strategies for improving dental practice culture.

>> FlipBook Version (Available in English)

>> Mobile-Friendly Version (Available in Multiple Languages)

Click here to access Asia's first Open-Access, Multi-Language Dental Publication

DEXIS Unveils Dental Imaging Technologies at 2023 GNYDM

USA: Dental imaging solutions innovator, DEXIS, is set to showcase its latest advancements at the 2023 Greater New York Dental Meeting (GNYDM). Attendees will have the opportunity for hands-on experience with two groundbreaking releases: DEXIS OP 3D LX and DEXassist Solution.

DEXIS OP 3D LX Features Live Demonstrations

At GNYDM, dental professionals will get a firsthand look at the DEXIS ORTHOPANTOMOGRAPH™ OP 3D™ LX. Key features to be demonstrated include a larger field of view (FOV) up to 15(H) x 20(D) cm, seamless integration with DTX Studio™ Clinic Software, simple patient positioning, consistent image clarity, and cloud-based service connectivity.

Read: DEXIS Introduces DEXassist Solution Powered by AI

Robert Befidi, President, Diagnostics at DEXIS, emphasizes, “The OP 3D LX offers expanded 2D and 3D imaging options, covering a comprehensive range of dental extraoral needs. We’ll showcase how it integrates AI features from DTX Studio Clinic, streamlining tasks for clinicians.”

DEXassist Solution Enhances Workflow Efficiencies

DEXassist Solution, seamlessly integrating with DEXIS Imaging Suite Software, captures 2D X-ray images and enhances workflow efficiencies with AI. This solution aids in identifying potential pathologies, leveraging a large installed base of DEXIS sensors.

Brian Gooch, Global Product Management and Marketing Vice President at DEXIS, states, “DEXassist Solution demonstrates DEXIS’s commitment to innovation, supporting diagnostic confidence and driving practice efficiencies.”

Visit Booth 2306 for Live Demonstrations

DEXIS invites GNYDM attendees to booth number 2306 for live demonstrations of these cutting-edge solutions. This offers an opportunity for dental professionals to explore DEXIS innovations and discuss their practice needs and goals.

Read: DEXIS Launches Next-Generation OP 3D LX

About DEXIS

DEXIS, a global digital radiography leader for over 70 years, integrates trusted brands in 3D imaging, intraoral scanning solutions, and diagnostic software. Their award-winning technology enhances diagnostics, accelerates workflows, and delivers better patient outcomes.

About Envista Holdings Corporation

Envista, a global family of dental brands, including DEXIS, Nobel Biocare, Ormco, and Kerr, collaborates with professionals to improve lives through dental consumables, solutions, technology, and services. With a comprehensive portfolio covering clinical needs, Envista is dedicated to meeting the end-to-end requirements of dental professionals worldwide.

The information and viewpoints presented in the above news piece or article do not necessarily reflect the official stance or policy of Dental Resource Asia or the DRA Journal. While we strive to ensure the accuracy of our content, Dental Resource Asia (DRA) or DRA Journal cannot guarantee the constant correctness, comprehensiveness, or timeliness of all the information contained within this website or journal.

Please be aware that all product details, product specifications, and data on this website or journal may be modified without prior notice in order to enhance reliability, functionality, design, or for other reasons.

The content contributed by our bloggers or authors represents their personal opinions and is not intended to defame or discredit any religion, ethnic group, club, organisation, company, individual, or any entity or individual.

Leave a Reply

Your email address will not be published. Required fields are marked *